Trade Biomerieux - BIM CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.50 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.021418% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000804% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | France | ||||||||
| Commission on trade | 0% |
| Prev. Close | 109.95 |
| Open | 109.75 |
| 1-Year Change | 20.34% |
| Day's Range | 107.65 - 110.05 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 13, 2024 | 109.95 | -0.20 | -0.18% | 110.15 | 110.85 | 109.35 |
| Sep 12, 2024 | 109.85 | 0.00 | 0.00% | 109.85 | 110.35 | 108.55 |
| Sep 11, 2024 | 108.55 | -0.10 | -0.09% | 108.65 | 110.35 | 107.95 |
| Sep 10, 2024 | 109.65 | 0.00 | 0.00% | 109.65 | 110.25 | 109.15 |
| Sep 9, 2024 | 110.65 | 3.90 | 3.65% | 106.75 | 111.35 | 106.05 |
| Sep 6, 2024 | 105.35 | -1.40 | -1.31% | 106.75 | 107.55 | 105.35 |
| Sep 5, 2024 | 107.05 | 0.20 | 0.19% | 106.85 | 108.25 | 104.65 |
| Sep 4, 2024 | 103.35 | 2.40 | 2.38% | 100.95 | 104.05 | 100.75 |
| Sep 3, 2024 | 101.85 | 0.90 | 0.89% | 100.95 | 102.65 | 100.05 |
| Sep 2, 2024 | 101.65 | -2.80 | -2.68% | 104.45 | 104.65 | 101.25 |
| Aug 30, 2024 | 104.55 | 1.70 | 1.65% | 102.85 | 105.55 | 102.85 |
| Aug 29, 2024 | 104.85 | -0.50 | -0.47% | 105.35 | 105.85 | 104.65 |
| Aug 28, 2024 | 104.75 | 0.30 | 0.29% | 104.45 | 105.55 | 104.15 |
| Aug 27, 2024 | 103.95 | 0.70 | 0.68% | 103.25 | 104.25 | 103.25 |
| Aug 26, 2024 | 103.65 | 0.50 | 0.48% | 103.15 | 103.85 | 102.95 |
| Aug 23, 2024 | 103.65 | 0.00 | 0.00% | 103.65 | 104.25 | 101.75 |
| Aug 22, 2024 | 103.65 | 2.65 | 2.62% | 101.00 | 104.45 | 100.50 |
| Aug 21, 2024 | 98.25 | 0.30 | 0.31% | 97.95 | 99.10 | 96.90 |
| Aug 20, 2024 | 97.60 | -0.70 | -0.71% | 98.30 | 99.40 | 97.60 |
| Aug 19, 2024 | 98.60 | 0.20 | 0.20% | 98.40 | 98.95 | 98.20 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Biomerieux Company profile
About BioMerieux SA
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, BioMerieux SA revenues increased 8% to EUR3.38B. Net income applicable to common stockholders increased 49% to EUR601.1M. Revenues reflect Microbiology segment increase of 12% to EUR1.06B, Molecular Biology segment increase of 5% to EUR1.27B, Europe & Middle East & Africa (EMEA) (Region) segment increase of 10% to EUR1.12B, America segment increase of 5% to EUR1.67B.
Equity composition
9/2017, 3-for-1 stock split (Factor: 3).
| Industry: | Laboratory Diagnostic & Testing Substances |
376, chemin de l'Orme
CRAPONNE
AUVERGNE-RHONE-ALPES 69280
FR
News
FOMC Decision Preview
As the US Federal Reserve prepares for its most significant decision since ending the rate hike cycle in mid-2023, the balance of risks has shifted. With inflation stabilizing at 2.6% and rising unemployment at 4.2%, the FOMC faces increasing pressure to address employment concerns. Markets anticipate a rate cut, with debate on the extent of the reduction.
09:48, 16 September 2024
ECB Preview: cuts expected but the pace is uncertain
Markets expect the ECB to cut rates again in September, but how many more?
12:34, 11 September 2024
Market analysis: US CPI and PPI
Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.
07:56, 10 September 2024
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com